Ligand Pharmaceuticals to present at multiple investor conferences in May 2026

Ligand Pharmaceuticals announced that its senior management will participate in several investor conferences throughout May 2026, including virtual and in-person events such as the H.C. Wainwright Royalty Company Conference and the Bank of America Healthcare Conference. These appearances include fireside chats and one-on-one meetings, providing opportunities for investors to engage directly with the company. Ligand is a leading biopharma royalty aggregator with a diverse portfolio, aiming to deliver consistent revenue through strategic partnerships and licensing proprietary technologies. This active investor engagement signals Ligand's commitment to transparency and growth in the biopharmaceutical sector.